Dyadic International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
$DYAI
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported) : June 20, 2025
(Exact name of registrant as specified in its charter)
|
(State or other jurisdiction of
incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification Number)
|
|
|
||
|
(Address of principal executive offices and zip code)
|
||
|
(
|
||
|
(Registrant’s telephone number, including area code)
|
||
|
N/A
(Former Name or Former Address, if Changed Since Last Report)
|
||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||||||
|
|
|
The
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 20, 2025, Dyadic International, Inc. (“Dyadic” or the “Company”) held its 2025 Annual Meeting of Shareholders (the “2025 Annual Meeting”). The final voting results with respect to each proposal voted upon at the 2025 Annual Meeting are set forth below:
Proposal 1: Election of Class III Directors to serve until the Company's 2028 Annual Meeting of Shareholders.
|
Nominee
|
For
|
Withheld
|
Broker Non-Votes
|
|||||||
| Mark A Emalfarb | 15,946,385 | 421,896 | 7,892,709 |
Proposal 2: Ratification of Appointment of Crowe LLP as the Company's Independent Registered Public Accounting Firm for the current fiscal year ending December 31, 2025.
|
For
|
Against
|
Abstained
|
|||||
| 24,013,307 | 237,523 | 10,160 |
Proposal 3: Advisory Vote on compensation of the Company's Named Executive Officers.
|
For
|
Against
|
Abstained
|
Broker Non-Votes
|
|||||||
| 15,765,072 | 522,744 | 80,465 | 7,892,709 |
Proposal 4: Advisory Vote on the frequency of the advisory vote on compensation of the Company's Named Executive Officers.
| 1 Year | 2 Years | 3 Years | Abstained | |||||||
| 15,443,558 | 716,692 | 13,576 | 194,455 |
In light of these voting results, the board of directors (the “Board”) and the Compensation Committee of the Board have determined that future advisory votes on the Company's executive compensation program shall occur once every one year.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: June 24, 2025
|
Dyadic International, Inc.
|
||
|
By:
|
/s/ Ping W. Rawson
|
|
|
Name:
|
Ping W. Rawson
|
|
|
Title:
|
Chief Financial Officer
|
|